Alcohol Septal Ablation: Technique and Outcome

  • Paul SorajjaEmail author


Dynamic left ventricular outflow tract obstruction is common in patients with hypertrophic cardiomyopathy, and can be associated with debilitating symptoms of heart failure. For those patients with drug-refractory symptoms, alcohol septal ablation is an effective therapy. The outcomes of alcohol septal ablation can approach the gold standard of surgical myectomy when performed in selected patients and in centers that are dedicated to the comprehensive, longitudinal care of patients with HCM.


Ablation Hypertrophic Cardiomyopathy Catheter Hemodynamics Obstruction 


  1. 1.
    Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–20.PubMedGoogle Scholar
  2. 2.
    Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58:e212–60.PubMedCrossRefGoogle Scholar
  4. 4.
    Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surgical myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Sorajja P, Ommen SR, Holmes Jr DR, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374–80.PubMedCrossRefGoogle Scholar
  7. 7.
    Valeti US, Nishimura RA, Holmes DR, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;49:350–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Talreja DR, Nishimura RA, Edwards WD, et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol. 2004;44:2329–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Sorajja P, Valeti U, Nishimura RA, et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008;118:131–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Sorajja P, Binder J, Nishimura RA, et al. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2013;81:E58–67.PubMedCrossRefGoogle Scholar
  11. 11.
    Van Dockum WG, Beek AM, ten Cate FJ, et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 2005;111:2503–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Singh M, Edwards WD, Holmes Jr DR, Tajik AJ, Nishimura RA. Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc. 2001;76:799–802.PubMedCrossRefGoogle Scholar
  13. 13.
    Firoozi S, Elliott PM, Sharma S, Murday A, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy: a comparison of clinical, hemodynamic and exercise outcomes. Eur Heart J. 2002;23:1617–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Nagueh S, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001;38:1701–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. 2001;38:1994–2000.PubMedCrossRefGoogle Scholar
  16. 16.
    Ralph-Edwards A, Woo A, McCrindle BW, et al. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg. 2005;129:351–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Jiang TY, Wu XS, Lu Q, et al. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy. Chin Med J. 2004;117:296–8.PubMedGoogle Scholar
  18. 18.
    Vural AH, Tiryakioglu O, Turk T, et al. Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation. Heart Surg Forum. 2007;10:493–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Fernandes VL, Nielsen C, Nagueh SF, et al. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv. 2008;1:561–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Kwon DH, Kapadia SR, Tuzcu EM, et al. Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. JACC Cardiovasc Interv. 2008;1:432–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Ten Cate FJ, Solimon OI, Michels M, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution. Circ Heart Fail. 2010;3:362–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Faber L, Seggewiss H, Gleichman U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Results with respect to intraprocedural myocardial contrast echocardiography. Circulation. 1998;98:2415–21.PubMedCrossRefGoogle Scholar
  23. 23.
    Nagueh SF, Groves BM, Schwartz L, et al. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol. 2011;58:2322–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Agarwal S, Tuzcu EM, Desai MY, et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;55:823–34.PubMedCrossRefGoogle Scholar
  25. 25.
    Alam M, Doakinsih H, Lakkis NM. Hypertrophic obstructive cardiomyopathy- alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J. 2009;30:1080–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Olivotto I, Ommen SR, Maron MS, Cecchi F, Maron BJ. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial. J Am Coll Cardiol. 2007;50:831–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2015

Authors and Affiliations

  1. 1.Department of Interventional CardiologyCenter for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern HospitalMinneapolisUSA

Personalised recommendations